10 results
P
Hu ML, Zheng G, Lin H, Yang M, Zhang YD, Han JM
I/C
Desensitizing Toothpastes
O
Dentine Hypersensitivity
P
E2F4, FOXM1, TFDP1, E2F1, SIN3A, JUN, DDX4, FOSL1, NOC2L, HMGA1, CDK1, CCNB1, AURKA, CDC20, CCNA2, SCNN1A, CDCA3, SOX6
I/C
O
survival prognosis, immune infiltrations, diagnostic efficacy
P
7683 subjects
I/C
systematic search and meta-analysis, EAT density values in patients with coronary artery disease vs. healthy subjects
O
EAT density values, correlations between EAT density and segmentation thresholds
P
patients who meet WHO dual X-ray absorptiometry (DXA) osteoporosis criteria
I/C
computed tomography (CT) images, DXA scans
O
diagnosis of osteoporosis
P
8050 patients
I/C
Cyclosporine + methotrexate + Anti-T cell globulin (ATG), tacrolimus + methotrexate + ATG, tacrolimus + bortezomib + sirolimus, cyclosporine + marrow mesenchymal stem cells (MMSCs), corticosteroids alone
O
proportion of patients who respond to therapies
P
ALE patients
I/C
immunotherapy, no definite evidence supporting the notion that different AAB-types of ALE exhibit distinct neuropsychological manifestations and respond differently to immunotherapy
O
no effect of immunotherapy on cognition in ALE
P
advanced gallbladder cancer patients
I/C
palliative chemotherapy
O
survival, adverse effects
P
adult population, over 60 years old, under 18 years old
I/C
reminder sent by mail
O
adherence to influenza vaccination
P
pacientes con COVID-19
I/C
inhibidores de la enzima convertidora de angiotensina, bloqueadores del receptor de angiotensina II, placebo o ningún tratamiento
O
efectos sobre la COVID-19